India's SMS Pharma jumps after US FDA clears facility
** Shares of SMS Pharmaceuticals SMSP.NS jump 7.4% to 248.48 rupees; set for best day since late-April ** The U.S. FDA concluded inspection at its Hyderabad facility in Telangana state with no observations ** Stock on track for busiest trading session in two months, volumes at 7.7x the 30-day avg ** Year-to-date, stock up 4% (Reporting by Manvi Pant in Bengaluru) ((Manvi.Pant@thomsonreuters.com; +918447554364;))
Recent news on SMS Pharmaceuticals
See all newsBrief: SMS Pharmaceuticals Ltd Q2 Consol Net Profit INR 398.5 Million
Brief: SMS Pharmaceuticals March-Quarter Consol Net Profit 327.1 Million Rupees
Brief: Sms Pharmaceuticals Says Tax Demand Reduced To 4 Million Rupees From 71.9 Million Rupees
Advisory: Alert incorrectly tagged to SMS Phramaceuticals withdrawn
Brief: SMS Pharmaceuticals Says Completion Of USFDA Inspection At Vizag Manufacturing Facility